PTGS2 and tuberculosis: Several FDA-approved medicines, including all-trans retinoic acid (ATRA), cyclooxygenase-2 inhibitor (COX-2i), phosphodiesterase-5 inhibitor (PDE-5i), and sildenafil, have been validated in the treatment of tuberculosis (TB) (61, 69, 74–76).